Multivalent clostridial toxins
AssigneeAllergan, Inc.
InventorsLance E. Steward, Ester Fernandez-Salas, Joseph Francis, Shengwen Li, Marcella A. Gilmore, Kei Roger Aoki
Life of this patent
Estimating the term…
Loading patent…
AssigneeAllergan, Inc.
InventorsLance E. Steward, Ester Fernandez-Salas, Joseph Francis, Shengwen Li, Marcella A. Gilmore, Kei Roger Aoki
Estimating the term…
The present invention is directed to multivalent Clostridial toxin comprising more than one binding domain directed to a cell surface molecule of a target cell. Such modified toxins are useful as therapeutic compositions to prevent exocytosis and secretion by the target cell. Conditions in which such compositions may be useful include, without limitation, disorders of the sensory or motor nervous system, acute or chronic pain, cancer, pancreatitis, hyperhydrosis, glandular disorders, viral infections, cystic fibrosis and the like. The invention is also directed to methods of using and administering such a composition, and methods of treating a given condition using such a composition.
A polynucleotide molecule encoding a multivalent Clostridial toxin, wherein the multivalent Clostridial toxin comprises:
Dependencies are inferred from the claim text.